Drugs / Tiotropium/Salmeterol
last change Jul 2009 re-read 2 minutes ago

Tiotropium/Salmeterol

Developed for
chronic obstructive pulmonary disease
Investigated by
Boehringer Ingelheim

Trials 1 · a red edge is where a trial was stopped

20082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT00662792 Apr 2008 → Jul 2009 chronic obstructive pulmonary disease Boehringer Ingelheim Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Tiotropium/Salmeterol ClinicalTrials.gov intervention name — accepted as the source's own label NCT00662792
Route Inhaled “inhalation powder” NCT00662792